Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles
Introduction: In etiology of Alzheimer’s disease (AD), involvement of amyloid β (Aβ) plaque accumulation and oxidative stress in the brain have important roles. Several nanoparticles such as titanium dioxide, silica dioxide, silver and zinc oxide have been experimentally using for treatment of neuro...
| 出版年: | Expert Review of Clinical Pharmacology |
|---|---|
| 第一著者: | |
| フォーマット: | Review |
| 言語: | English |
| 出版事項: |
Taylor and Francis Ltd
2017
|
| オンライン･アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021103809&doi=10.1080%2f17512433.2017.1324781&partnerID=40&md5=c4279183e800673b1cd805c82ffadca3 |